SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Syschem (India) - Quaterly Results

02 Nov 2022 Evaluate
The Top line for the quarter ended September 2022 of Rs. 224.91 millions up 77.57% from Rs. 126.66 millions.The Total Profit for the quarter ended September 2022 of Rs. 13.40 millions grew from Rs.-17.13 millions Operating profit Margin for the quarter ended September 2022 improved to 20.74% as compared to -10.57% of corresponding quarter ended September 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 224.91 126.66 77.57 388.49 322.19 20.58 656.33 744.15 -11.80
Other Income 1.34 0.20 570.00 1.85 0.22 740.91 1.26 2.56 -50.78
PBIDT 20.74 -10.57 -296.22 34.73 -19.18 -281.07 6.93 -49.04 -114.13
Interest 0.21 0.22 -4.55 0.28 0.30 -6.67 2.84 0.55 416.36
PBDT 20.53 -10.79 -290.27 34.45 -19.48 -276.85 4.09 -49.59 -108.25
Depreciation 7.13 6.34 12.46 13.96 12.54 11.32 25.81 23.55 9.60
PBT 13.40 -17.13 -178.23 20.49 -32.02 -163.99 -21.72 -73.14 -70.30
TAX 0.00 0.00 0.00 0.00 0.00 0.00 -4.66 -17.49 -73.36
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -4.66 -17.49 -73.36
PAT 13.40 -17.13 -178.23 20.49 -32.02 -163.99 -17.06 -55.65 -69.34
Equity 305.40 232.90 31.13 305.40 232.90 31.13 232.90 215.40 8.12
PBIDTM(%) 9.22 -8.35 -210.50 8.94 -5.95 -250.17 1.06 -6.59 -116.02

Syschem (India) Share Price

40.91 0.27 (0.66%)
06-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1913.05
Dr. Reddys Labs. 1368.75
Cipla 1471.25
Zydus Lifesciences 1148.05
Lupin 2492.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: